Pharmaceutical formulation
US8506998B2 · kind B2 · utility
11Cited by
61References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2006 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Dec 18, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid, oral controlled release pharmaceutical dosage form has a water-soluble active ingredient dispersed in a matrix and releases the active ingredient at such a rate upon administration that the median tmax is 2.5 to 6 hours and the ratio of mean Cmax to mean plasma level of the active ingredient at 24 hours is in the range of 1.5 to 3.5.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.